Related Experiment Video
Updated: Mar 14, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Current Immunotherapies for Sarcoma: Clinical Trials and Rationale.
Demytra Mitsis1, Valerie Francescutti2, Joseph Skitzki3
1Department of Medical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Sarcoma
|October 6, 2016
Summary
Immunotherapies, including vaccines and cellular treatments, show promise for rare sarcoma tumors. Emerging immunologic checkpoint inhibitors are expected to improve clinical efficacy and drive further research in sarcoma treatment.
Area of Science:
- Oncology
- Immunology
Background:
- Sarcoma tumors, though rare and diverse, exhibit features amenable to immunotherapy.
- Existing active (vaccines) and passive (cellular adoptive) immunotherapies have shown patient benefits.
Approach:
- Clinical trials have explored various immunotherapeutic strategies for sarcoma.
- The integration of immunologic checkpoint inhibition into sarcoma treatment is a recent development.
Key Points:
- Immunotherapies, including vaccines and adoptive cell transfer, offer potential benefits for select sarcoma patients.
- Immunologic checkpoint inhibition is a rapidly advancing area with anticipated efficacy across sarcoma types.
Conclusions:
- Emerging immunotherapies are poised to demonstrate clinical efficacy in diverse sarcoma subtypes.
- Personalized immunologic therapies for sarcoma patients will likely spur increased clinical research and enthusiasm.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
02:49Cancer Therapies
2.9K
2.9K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:11Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K